These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3828557)

  • 21. Clinical implications of tumor-cell heterogeneity.
    Schnipper L
    N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
    Skipper HE; Simpson-Herren L
    Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
    [No Abstract]   [Full Text] [Related]  

  • 23. Modelling the process of drug resistance.
    Goldie JH
    Lung Cancer; 1994 Mar; 10 Suppl 1():S91-6. PubMed ID: 7916254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian cancer pharmacodynamics.
    Hrushesky WJ
    Ann Ist Super Sanita; 1993; 29(4):705-10. PubMed ID: 7985931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cancer stem cells and chemotherapy].
    Gligorov J; Benderra MA; Zaoui M; Sabbah M; Larsen A
    Bull Cancer; 2017 Dec; 104(12):1085-1087. PubMed ID: 29162224
    [No Abstract]   [Full Text] [Related]  

  • 26. Reanalysis of cancer drugs: old drugs, new tricks.
    Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
    Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
    [No Abstract]   [Full Text] [Related]  

  • 27. Interactions between antitumour agents and radiation and the expression of resistance.
    Hill BT
    Cancer Treat Rev; 1991 Sep; 18(3):149-90. PubMed ID: 1821327
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of tumor stroma on drug response in breast cancer.
    Dittmer J; Leyh B
    Semin Cancer Biol; 2015 Apr; 31():3-15. PubMed ID: 24912116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting the development of permanent drug resistance and its impact upon neoadjuvant chemotherapy.
    Coldman AJ; Goldie JH
    Recent Results Cancer Res; 1986; 103():69-78. PubMed ID: 3738197
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics in cancer stem cells.
    Toh TB; Lim JJ; Chow EK
    Mol Cancer; 2017 Feb; 16(1):29. PubMed ID: 28148257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of chemotherapy and cancer stem cell targeting agents: Preclinical and clinical studies.
    Li Y; Atkinson K; Zhang T
    Cancer Lett; 2017 Jun; 396():103-109. PubMed ID: 28300634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Role of mathematical modeling in protocol formulation in cancer chemotherapy".
    Rosen R
    Cancer Treat Rep; 1986 Dec; 70(12):1461-2. PubMed ID: 3791260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Strategies for the overcoming of drug resistance].
    Saijo N
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):371-81. PubMed ID: 7880108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort.
    Michor F; Beal K
    Cell; 2015 Nov; 163(5):1059-1063. PubMed ID: 26590416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-derived tumor organoids for prediction of cancer treatment response.
    Nagle PW; Plukker JTM; Muijs CT; van Luijk P; Coppes RP
    Semin Cancer Biol; 2018 Dec; 53():258-264. PubMed ID: 29966678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approaches to target cancer initiating cells-eliminating the root of the cancer.
    McCubrey JA; Abrams SL; Umezawa K; Cocco L; Martelli AM; Franklin RA; Chappell WH; Steelman LS
    Adv Biol Regul; 2012 Jan; 52(1):249-64. PubMed ID: 21930143
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental basis of antileukaemic chemotherapy.
    Messner HA
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():20-5. PubMed ID: 2653504
    [No Abstract]   [Full Text] [Related]  

  • 39. A mathematical model of cancer chemotherapy with an optimal selection of parameters.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1990 May; 99(2):205-30. PubMed ID: 2134520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory models: some historical perspective.
    Skipper HE
    Cancer Treat Rep; 1986 Jan; 70(1):3-7. PubMed ID: 3943114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.